AKT1 and leukemia: To conclude, our present results suggest that disrupting PI3K/Akt/mTOR signaling can alter the local bone marrow cytokine network both through effects on leukemia cells as well as various stromal cells, and these alterations may directly affect the leukemic cells or indirectly affect leukemogenesis through altered regulation of bone marrow angiogenesis.